Associate Director, Strategy & Operations · GSK

Dr. Namarta Jain.

I lead global omnichannel & digital transformation in pharma — turning strategy into operations at enterprise scale, and connecting creative, medical and commercial teams.

I'm known for scaling global teams
Scroll
0+
Years across
global pharma
0B
Portfolio scope
under Cx remit
0
Emerging markets
operationalized
0+
Associates led
at peak scale
What I do

I connect the three worlds that usually don't talk to each other.

Omnichannel excellence only happens when creative, medical and commercial move as one. That connective work is where I operate.

Creative

End-to-end content

E2E content strategy and execution, modular content and creative operations run as operational excellence at global scale.

Medical

Customer experience

Customized, compliant omnichannel customer experience (Cx) — connecting medical rigor with data-driven engagement.

Commercial

Strategy & operations

Digital-first go-to-market, vendor and budget management, and scaling teams that move both topline and bottom line.

Global omnichannel operations Operational excellence Setting up & scaling global teams Large-scale change management Strategic vendor management Negotiation Budget accountability Senior stakeholder management Enabling AI at scale
Career explorer

A decade of scale-ups, transformations & global launches.

Pick a chapter to explore the roles and impact.

Mumbai, India

GlaxoSmithKline

Aug 2019 — Present
Associate Director, Strategy & OperationsOct 2023 — Present
Digital Accelerator, Global Digital Fuel
  • Driving digital & omnichannel Cx transformation globally across a portfolio of ~£3.5 billion.
  • Core member of the Digital Accelerator leadership team; multi-country team scaled 5× in 15 months.
  • Spearheading AI initiatives for Cx transformation and operational excellence.
Senior Commercial Operations ManagerSep 2022 — Oct 2023
Content & Marketing Operations, Global Digital Fuel
  • Stood up the EMPower Engine across APAC, MEA & LATAM; revamped the global shared-services model.
  • Managed transition & full scale-up for 72 markets and 200+ FTEs with £4.0M budget accountability.
Commercial Operations Manager, Design CentreAug 2020 — Aug 2022
Global Pharma Marketing Operations
  • Led the Design Centre (250+ associates, ~£4M) operationalizing GSK's global omnichannel strategy for 72 markets.
  • Delivered direct cost benefits of £2.01M; onboarded 21 global brands; 30% SLA improvement (CSAT 4.9/5).
Design Centre ManagerAug 2019 — Jul 2020
Global Marketing Centre of Excellence
  • Managed ~300 associates (~£4M); budget optimization of ~£820K and CSAT response rate up 10×.
Hyderabad, India

Novartis

Aug 2017 — Aug 2019
Global Lifecycle Implementation Expert
Global supply & commercial operations
  • Led strategic lifecycle events for Gilenya, Tasigna, Femara & Sebivo across 130 countries.
  • Global core team for pediatric launches (patent extensions) and Sebivo divestment; drove data-based supply decisions.
  • Founder member of iNOVate; co-led a blockchain implementation for patient-support-program transparency.
India

Earlier roles

2011 — 2017 · Marketing, research & clinical practice
Marketing Dissertation — Lupin Pharmaceuticals2016 — 2017
  • Built the brand plan for anti-diabetic "Gluconorm G" through primary & secondary research across Mumbai & Delhi.
Marketing Intern, CNS — Sanofi2016
  • Formulated a plan to expand Sanofi's neurology portfolio into an untapped psychiatrist prescriber base.
Dental Surgeon2011 — 2015
Private practice, New Delhi · Manav Rachna Dental College
  • General dentistry and clinical practice before transitioning into pharma strategy and operations.
Global reach

Operations that span the map.

From 72 emerging markets at GSK to 130 countries of lifecycle work at Novartis — drag the globe to spin it.

Emerging markets (GSK)72
Countries — lifecycle (Novartis)130
Regions run: APAC · MEA · LATAM · EU4
Global brands onboarded to omnichannel21
Active marketsNetwork
Recognition

Recognized — globally, and at the very top.

Twice named by GSK's Global CEO among the company's most impactful performers. Filter the wall below.

20+Global awards & recognitions
2025Bronze
Led the 2026 strategic roadmap for the Digital Accelerator team.
GSK · Global
2025Silver
Led a four-yearly global audit, concluding with no findings.
GSK · Global
2024Silver
ViiV Global Digital-plus GTM model — set up in a record 3 months.
GSK · Global
2024Program
Selected for WeLeAP — GSK's diverse senior-leadership pipeline.
GSK · Global
2023CEO
Ahead Together award — exceptional performer, recognized by Global CEO Emma Walmsley.
GSK · Global
2023Gold
Setting up the EMPower Engine for Emerging Markets.
GSK · Global
2023Bronze
Digital-only promotion of Ellipta across the EU.
GSK · Global
2022Gold
Scaling up data-driven Cx across Emerging Markets.
GSK · Global
2022Silver
Closing the COVID IMT with Tech Mahindra for the Design Centre.
GSK · Global
2021CEO
IPTC Award — one of the most impactful performers, recognized by Global CEO Emma Walmsley.
GSK · Global
2021Silver
Leading data-driven customer experience across CEP & Emerging Markets.
GSK · Global
2020Gold
Independent accountability of GSK's COVID-19 Business Continuity Plan.
GSK · Global
2018Talent
Exceptional talent recognition, FY 2018–19.
Novartis
2017–19Applause
Four Global Applause Awards across a two-year tenure.
Novartis
— plus a further set of global silver, bronze & appreciation awards across 2021–2023 —
Foundation

A deliberately blended background.

MBA — Pharma Management
NMIMS, Mumbai
Jun 2015 — Apr 2017Grade A · Gold Medalist
BDS — Dental Surgery
Maharishi Dayanand University
Oct 2007 — Sep 2012Grade A
PG — Digital Marketing
Purdue University, US
Jul 2021 — Aug 2022
Certified Scrum Product Owner
Agile · PMP – PMI (USA) trained
Aug 2019
Get in touch

Let's talk about scaling what matters.

Open to conversations on global omnichannel transformation, operational leadership and enabling AI at enterprise scale.